Cosmos Gastro And Laparoscopy Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
as on 20-12-2024
- Revenue %
(FY 2022)
- Profit -500.83%
(FY 2022)
- Ebitda -23.50%
(FY 2022)
- Net Worth
- Total Assets 6.34%
(FY 2022)
About Cosmos Gastro And Laparoscopy Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 Cr.
Achal Agrawal, Bhagwan Thakur, and Neetu Thakur serve as directors at the Company.
- CIN/LLPIN
U85110MP2020PTC051130
- Company No.
051130
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cosmos Gastro And Laparoscopy Hospital?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Achal Agrawal  | Director | 05-Mar-2020 | Current |
| Bhagwan Thakur | Director | 05-Mar-2020 | Current |
| Neetu Thakur | Director | 05-Mar-2020 | Current |
Financial Performance of Cosmos Gastro And Laparoscopy Hospital.
Cosmos Gastro And Laparoscopy Hospital Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 500.83% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosmos Gastro And Laparoscopy Hospital?
Unlock access to Cosmos Gastro And Laparoscopy Hospital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹40.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Aug 2020 | Others | ₹4.00 Cr | Open |
How Many Employees Work at Cosmos Gastro And Laparoscopy Hospital?
Unlock and access historical data on people associated with Cosmos Gastro And Laparoscopy Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosmos Gastro And Laparoscopy Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmos Gastro And Laparoscopy Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.